Molecular docking study of hyaluronic acid against interleukin-6 (7DC8 protein) in COVID-19 patients with periodontitis

Authors

  • Ade Ismail Periodontic Specialist Program, Faculty of Dentistry, Sultan Agung Islamic University, Semarang, Indonesia
  • Syafirudin Aulia Azhar Department of Periodontics, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

DOI:

https://doi.org/10.31436/ijohs.v4i2.219

Keywords:

COVID-19, hyaluronic acid, molecular docking, periodontitis

Abstract

Coronavirus disease 2019 (COVID-19) is a new disease caused by a coronavirus, namely SARS-CoV-2. This virus was entered inside the host by angiotensin-converting enzyme receptors (ACE2). Recent evidence suggests that sulcus fluid in the periodontal pockets of patients with periodontitis may be a source of SARS-CoV-2 and a potential reservoir for increasing oral viral load in patients with confirmed COVID-19. ACE-2 is expressed in stratified squamous epithelium mainly on the dorsal tongue and gingiva. The gingival sulcular epithelium is the entry point for SARS-CoV-2 into the periodontal pocket epithelium through the gingival crevicular fluid (GCF). Hyaluronic acid (HA) is a high molecule of heavy polysaccharide (glycosaminoglycan) which has several functions, such as anti-inflammatory and accelerated wound healing. It could decrease the levels of several cytokines. This study aims to analyze the interaction of HA against the IL-6 coronavirus receptor in periodontitis through a molecular docking study using MOE 2015.10 software with IL-6 receptor (7DC8) as the protein model to predict the binding of HA with 10 poses. The 7DC8 protein was prepared by adding charge and the validation method was performed with RMSD <2Å which indicates this method is valid. The results of this study showed that there are interaction between HA and the IL-6 receptor via amino acid residue interaction at the Leucine 98 (bond energy -0.7 kcal/mol), Serine 52 (bond energy -1.7 kcal/mol), Glycine 53 (bond energy -1.5 kcal/mol), and Glycine 299 (bond energy -1.6 kcal/mol).  HA has an interaction with coronavirus at the IL-6 receptor of periodontitis based on molecular docking study and can potentially be used as a therapeutic option in COVID-19 with periodontitis. In conclusion, hyaluronic acid has the potential as an anti-inflammatory drug of choice in COVID-19 patients with periodontitis.

References

Perhimpunan Dokter Paru Indonesia (2020). Panduan Praktik Klinis: Pneumonia 2019-nCoV, PDPI: Jakarta.

Zhou, P. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270-273.

Badran, Z., Gaudin, A., Struillou, X., Amador, G., and Soueidan, A. (2020). Periodontal pockets: a potential reservoir for SARS-CoV-2?. Medical Hypotheses, 143, 109907.

Sakaguchi, W., Kubota, N., Shimizu, T., Saruta, J., Fuchida, S., Kawata, A., et al. (2020). Existence of SARS-CoV-2 entry molecules in the oral cavity. International Journal of Molecular Sciences, 21, 6000.

Bertolini, M., Pita, A., Koo, S., Cardenas, A., and Meethil, A. (2020). Periodontal disease in the COVID-19 era: Potential reservoir and increased risk for SARS–CoV-2. Pesquisa Brasileira em Odontopediatria e Clínica Integrada, 20(supp1):e0140.

Molayem, S., and Pontes, C. (2020). The mouth-COVID connection: Il-6 levels in periodontal disease — potential role in COVID-19-related respiratory complication. Journal of the California Dental Association, 7, 1-44.

Wang, C., Horby, P. W., Hayden, F. G., and Gao, G. F. (2020) A novel coronavirus outbreak of global health concern. Lancet, 395, 470–473.

Hellman, U., Karlsson, M.G., Engström-Laurent, A., Cajander, S., Dorofte, L., Ahlm, C., et al. (2020). Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? Journal of Biological Chemistry, 295(45),15418-15422.

Wijayanto, R., Herawati, D., & Sudibyo (2014). Perbedaan efektivitas topikal gel asam hyaluronat dan gel metronidazol terhadap penyembuhan jaringan periodontal setelah kuretase pada Periodontitis Kronis. Jurnal Kedokteran Gigi, 5(2086–0218), 307–325.

Mesa, F.L., Aneiros, J., Cabrera, A., Bravo, M., Caballero, T., Revellas, F. (2002). Antiproliferative effect of topic hyaluronic acid gel. Study in gingival biopsies of patients with periodontal disease. Histology and Histopathology, 17, 747-753.

Rooney, P., Srivastava, A., Watson, L., Quinlan, L.R., Pandit, A. (2015). Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis. Acta Biomaterialia, 19, 66-75.

Jain, A.N. & Nicholls, A. (2008). Recommendations for evaluation of computational methods. Journal of Computer-Aided Molecular Design, 22, 133–139.

Attique, S. A., Hassan, M., Usman, M., Atif, R. M., Mahboob, S., Al-Ghanim, K. A., et al. (2019). A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. International Journal of Environmental Research and Public Health, 16(6), 923.

Downloads

Published

2023-07-31

How to Cite

Ismail, A., & Aulia Azhar, S. (2023). Molecular docking study of hyaluronic acid against interleukin-6 (7DC8 protein) in COVID-19 patients with periodontitis. IIUM Journal of Orofacial and Health Sciences, 4(2), 140–144. https://doi.org/10.31436/ijohs.v4i2.219